Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

OBJECTIVE: To explore cost-effectiveness of targeted therapies (TTs) in the treatment of metastatic renal cell carcinoma (mRCC) in a real-world context using a nationwide population-based approach. METHODS: Data on patients diagnosed with mRCC between 2002 and 2012 were extracted from Swedish nation...

Descripción completa

Detalles Bibliográficos
Autores principales: Redig, Josefine, Dalén, Johan, Harmenberg, Ulrika, Lindskog, Magnus, Ljungberg, Börje, Lundstam, Sven, Sandin, Rickard, Wahlgren, Thomas, Åkerborg, Örjan, Jakobsson, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371932/
https://www.ncbi.nlm.nih.gov/pubmed/30799955
http://dx.doi.org/10.2147/CMAR.S188849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371932/
https://www.ncbi.nlm.nih.gov/pubmed/30799955
http://dx.doi.org/10.2147/CMAR.S188849

Ejemplares similares